Published in Am J Cardiol on August 27, 2007
Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: the CARDIA study (Coronary Artery Risk Development in Young Adults). JACC Heart Fail (2014) 1.41
Body composition and coronary heart disease mortality--an obesity or a lean paradox? Mayo Clin Proc (2011) 1.02
The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging (2014) 1.01
Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction. Mayo Clin Proc (2011) 0.96
Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity. Hypertension (2012) 0.95
Impact of left ventricular geometry on prognosis-a review of ochsner studies. Ochsner J (2008) 0.90
Obesity-related hypertension. Ochsner J (2009) 0.87
Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study. J Am Heart Assoc (2015) 0.87
Relationship between left ventricular geometric pattern and systolic and diastolic function in treated Nigerian hypertensives. Cardiovasc J Afr (2010) 0.86
Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J (2009) 0.85
Molecular determinants of the cardiometabolic phenotype. Endocr Metab Immune Disord Drug Targets (2010) 0.84
The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study. Cardiovasc Diabetol (2016) 0.82
Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension. Pediatr Nephrol (2011) 0.81
Early changes of left ventricular geometry and deformational analysis in obese subjects without cardiovascular risk factors: a three-dimensional and speckle tracking echocardiographic study. Int J Cardiovasc Imaging (2014) 0.80
The russert impact: a golden opportunity to promote primary coronary prevention. Ochsner J (2008) 0.80
Cardiovascular consequences of obese and nonobese obstructive sleep apnea. Med Clin North Am (2010) 0.79
Preventive cardiology and non-invasive cardiology research at the ochsner clinic foundation. Ochsner J (2006) 0.78
Weight loss and progressive left ventricular remodelling: The Multi-Ethnic Study of Atherosclerosis (MESA). Eur J Prev Cardiol (2014) 0.77
Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging (2017) 0.76
Left Ventricular Geometry and Risk of Sudden Cardiac Arrest in Patients With Severely Reduced Ejection Fraction. J Am Heart Assoc (2016) 0.75
Relationship between body composition and left ventricular geometry using three dimensional cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2016) 0.75
Role of Cardiovascular Ultrasound in the Evaluation of Obese Subjects. J Cardiovasc Echogr (2017) 0.75
Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities). Circ Heart Fail (2016) 0.75
Heart disease is still a primary emphasis. Ochsner J (2009) 0.75
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40
Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol (2008) 7.04
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol (2009) 6.23
Obesity paradox in patients with hypertension and coronary artery disease. Am J Med (2007) 5.61
Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet (2008) 5.05
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA (2012) 4.92
Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med (2007) 4.20
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials. BMJ (2013) 3.98
Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.83
Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation (2011) 3.81
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA (2004) 3.20
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol (2007) 3.07
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol (2009) 2.83
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation (2010) 2.77
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol (2010) 2.77
Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med (2010) 2.33
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J (2010) 2.32
Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol (2004) 2.31
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension. J Hypertens (2014) 2.28
The obesity paradox, weight loss, and coronary disease. Am J Med (2009) 2.25
Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. J Heart Lung Transplant (2013) 2.23
Effect of allopurinol on blood pressure: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) (2012) 2.16
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail (2009) 2.10
Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy. Cleve Clin J Med (2011) 2.09
Evidence for early right ventricular and septal mechanical activation (interventricular dyssynchrony) in pulmonary hypertension. Am J Cardiol (2008) 2.08
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail (2008) 1.97
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study. Hypertension (2004) 1.90
Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant (2006) 1.84
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med (2003) 1.83
Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol (2003) 1.81
Obesity and cardiovascular disease: the hippocrates paradox? J Am Coll Cardiol (2003) 1.80
Associations between outpatient heart failure process-of-care measures and mortality. Circulation (2011) 1.77
Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol (2007) 1.76
Body composition and heart failure prevalence and prognosis: getting to the fat of the matter in the "obesity paradox". Mayo Clin Proc (2010) 1.75
Amyloidosis and the heart: a comprehensive review. Arch Intern Med (2006) 1.68
Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema. Am J Med (2011) 1.66
BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail (2004) 1.66
Lack of diagnostic and prognostic utility of circulating plasma myeloperoxidase concentrations in patients presenting with dyspnea. Clin Chem (2008) 1.57
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J (2012) 1.57
Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J (2013) 1.53
Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis. J Am Coll Cardiol (2008) 1.52
Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol (2004) 1.52
Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc (2010) 1.51
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. J Hypertens (2007) 1.51
Cardiac rehabilitation programs markedly improve high-risk profiles in coronary patients with high psychological distress. South Med J (2008) 1.50
Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST. Stroke (2007) 1.46
Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival. J Am Coll Cardiol (2002) 1.46
Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression. J Hypertens (2012) 1.45
Antihypertensive therapy and new onset diabetes. J Hypertens (2004) 1.45
Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol (2004) 1.44
Stopping stress at its origins. Hypertension (2007) 1.44
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol (2010) 1.43
Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol (2005) 1.42
Vitamin D and cardiovascular disease will it live up to its hype? J Am Coll Cardiol (2011) 1.41
It is time to stop ignoring malignancy in heart transplantation: a call to arms. J Heart Lung Transplant (2005) 1.41
All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy. Circulation (2006) 1.41
Cardiopulmonary exercise testing in patients with pulmonary arterial hypertension: an evidence-based review. J Heart Lung Transplant (2009) 1.41
Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period. Heart (2011) 1.41
Authors' reply to Laragh and Sealey. BMJ (2013) 1.40
The renin-angiotensin systems: evolving pharmacological perspectives for cerebroprotection. Curr Pharm Des (2005) 1.39
Of millimeterology and cannibalism: comparative antihypertensive efficacy of angiotensin receptor blockers. Am Heart J (2003) 1.39
Hippocrates and prognosis in heart failure: the challenge of static and dynamic measurements. Am Heart J (2003) 1.39
Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. Am J Cardiol (2010) 1.38
Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc (2009) 1.33
Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke (2006) 1.33
Left ventricular geometry and survival in patients with normal left ventricular ejection fraction. Am J Cardiol (2006) 1.32
Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) (2012) 1.29
Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis (2009) 1.27
Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction. Am J Cardiol (2006) 1.26
The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. J Am Coll Cardiol (2011) 1.25
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation (2004) 1.24
Beyond salt: lifestyle modifications and blood pressure. Eur Heart J (2011) 1.24
Salt and hypertension: is salt dietary reduction worth the effort? Am J Med (2012) 1.22
Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med (2006) 1.21
The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant (2011) 1.20
Impact of obesity on the risk of heart failure and its prognosis. J Cardiometab Syndr (2008) 1.20
C-reactive protein and cardiovascular diseases--is it ready for primetime? Am J Med Sci (2009) 1.20
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med (2010) 1.17
The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant (2016) 1.16
The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2013) 1.16